MedPath
HSA Approval

AMXOL TABLETS 30 mg

SIN02983P

AMXOL TABLETS 30 mg

AMXOL TABLETS 30 mg

May 20, 1989

MEDISPEC RENAISSANCE PTE. LTD.

MEDISPEC RENAISSANCE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDISPEC RENAISSANCE PTE. LTD.
Licence HolderMEDISPEC RENAISSANCE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R05CB06

ambroxol

Manufacturer Information

MEDISPEC RENAISSANCE PTE. LTD.

BIOLAB CO LTD

Active Ingredients

Ambroxol HCl

30 mg

Ambroxol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.